| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.2 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.041 | 0.2 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.09 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.2 |